These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34774874)

  • 1. Recent developments in drug delivery strategies for targeting DNA damage response in glioblastoma.
    Morás AM; Henn JG; Steffens Reinhardt L; Lenz G; Moura DJ
    Life Sci; 2021 Dec; 287():120128. PubMed ID: 34774874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
    Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
    Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into targeting the DNA damage response in the treatment of glioblastoma.
    Zhen T; Sun T; Xiong B; Liu H; Wang L; Chen Y; Sun H
    Chin J Nat Med; 2024 Oct; 22(10):869-886. PubMed ID: 39428180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel delivery strategies for glioblastoma.
    Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
    Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking Glioblastoma Therapy: MDA-9/Syntenin Targeted Small Molecule.
    Das SK; Sarkar D; Cavenee WK; Emdad L; Fisher PB
    ACS Chem Neurosci; 2019 Mar; 10(3):1121-1123. PubMed ID: 30681320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
    Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
    Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.
    Suwala AK; Hanaford A; Kahlert UD; Maciaczyk J
    J Neuropathol Exp Neurol; 2016 May; 75(5):388-96. PubMed ID: 26979081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
    Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrating the Blood-Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy.
    Tam DY; Ho JW; Chan MS; Lau CH; Chang TJH; Leung HM; Liu LS; Wang F; Chan LLH; Tin C; Lo PK
    ACS Appl Mater Interfaces; 2020 Jul; 12(26):28928-28940. PubMed ID: 32432847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma.
    Pena ES; Graham-Gurysh EG; Bachelder EM; Ainslie KM
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular neuro-oncology and the challenge of the blood-brain barrier.
    Aiken R
    Semin Oncol; 2014 Aug; 41(4):438-445. PubMed ID: 25173137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma.
    Branco F; Cunha J; Mendes M; Vitorino C; Sousa JJ
    ACS Nano; 2024 Jul; 18(26):16359-16394. PubMed ID: 38861272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations.
    Serwer LP; James CD
    Adv Drug Deliv Rev; 2012 May; 64(7):590-7. PubMed ID: 22306489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting to the brain.
    Baratta MG
    Nat Nanotechnol; 2018 Jul; 13(7):536. PubMed ID: 29921944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.